NASOPHARYNGEAL HN001

Study #HN001

Randomized Phase II and Phase III Studies of Individualized for Nasopharyngeal Carcinoma Base on Biomarker Epstein Barr Virus (EBV) Deoxyriboncleic Acid (DNA).

Back To Clinical Trials